Growth Metrics

Fulgent Genetics (FLGT) Change in Account Payables (2016 - 2026)

Fulgent Genetics' Change in Account Payables history spans 12 years, with the latest figure at -$408000.0 for Q1 2026.

  • On a quarterly basis, Change in Account Payables rose 37.99% to -$408000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $800000.0, a 69.85% decrease, with the full-year FY2025 number at $550000.0, down 82.06% from a year prior.
  • Change in Account Payables hit -$408000.0 in Q1 2026 for Fulgent Genetics, down from $924000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for FLGT hit a ceiling of $7.0 million in Q4 2022 and a floor of -$22.1 million in Q3 2022.
  • Historically, Change in Account Payables has averaged -$1.7 million across 5 years, with a median of -$245000.0 in 2024.
  • The widest YoY moves for Change in Account Payables: up 318.23% in 2022, down 1860.21% in 2022.
  • Tracing FLGT's Change in Account Payables over 5 years: stood at $7.0 million in 2022, then crashed by 98.16% to $129000.0 in 2023, then tumbled by 726.36% to -$808000.0 in 2024, then surged by 214.36% to $924000.0 in 2025, then plummeted by 144.16% to -$408000.0 in 2026.
  • Business Quant data shows Change in Account Payables for FLGT at -$408000.0 in Q1 2026, $924000.0 in Q4 2025, and -$102000.0 in Q3 2025.